Cytiva has acquired Precision NanoSystems, a Vancouver, Canada-based global leader in technologies, solutions, and services to support nanomedicine development for genomic medicine applications, including mRNA vaccines and therapeutics.
Accelerate your pipeline with rationally designed LNP formulations to validate active pharmaceutical ingredients (API). We offer an easily accessible and well-characterized lipid nanoparticle portfolio and nanomedicine formulation technologies for mRNA vaccines and future RNA-based therapeutics.
-
Pre-optimized LNP formulations
Speed up RNA-LNP drug development with optimized LNP formulations and advanced LNP technology.
-
A library of lipids
Screen and optimize lipids with custom, GLP, and GMP lipids to ensure efficient encapsulation.
-
Optimize LNP formulations
Because lipid nanoparticles affect RNA-LNP drug and vaccine delivery, potency, and biodistribution.
-
Lipid nanoparticle portfolio FAQs
Accelerate screening with a portfolio of ionizable lipids compositions, and formulation services.